| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.76 | 0.002 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.097 | 0.003 |